Plasma cell disorders

Adherence to immunomodulatory drugs in patients with multiple myeloma

Amélie Cransac, Serge Aho, [ ... ], Mathieu Boulin

Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma

Even H. Rustad, Malin Hultcrantz, [ ... ], Ola Landgren

Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma

Hareth Nahi, Michael Chrobok, [ ... ], Evren Alici

Extracellular vesicle-associated procoagulant phospholipid and tissue factor activity in multiple myeloma

Thøger Nielsen, Søren Risom Kristensen, [ ... ], Shona Pedersen

Differentiation of multiple myeloma and metastases: Use of axial diffusion-weighted MR imaging in addition to standard MR imaging at 3T

Ga Eun Park, Won-Hee Jee, [ ... ], Kee-Yong Ha

Clinical outcomes of bortezomib-based therapy in myeloma

Faouzi Djebbari, Anandagopal Srinivasan, [ ... ], Karthik Ramasamy

PCSeg: Color model driven probabilistic multiphase level set based tool for plasma cell segmentation in multiple myeloma

Anubha Gupta, Pramit Mallick, [ ... ], Rahul Duggal

Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013

Kari Remes, Pekka Anttila, [ ... ], Amy Leval

Regularization and grouping -omics data by GCA method: A transcriptomic case

Monika Piwowar, Kinga A. Kocemba-Pilarczyk, Piotr Piwowar

Macrophage Inhibitory Factor-1 (MIF-1) controls the plasticity of multiple myeloma tumor cells

Danielle Joseph, Jason P. Gonsky, Stacy W. Blain

Dietary intake is associated with risk of multiple myeloma and its precursor disease

Marianna Thordardottir, Ebba K. Lindqvist, [ ... ], Sigurdur Y. Kristinsson

A simple approach for multi-targeted shRNA-mediated inducible knockdowns using Sleeping Beauty vectors

Severin Fink, Laurens Zugelder, [ ... ], Thorsten Stühmer

Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials

Lucia Lopez-Anglada, Cecilia Cueto-Felgueroso, [ ... ], on behalf of the GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Group

Plasma cell disorders

Connect with Us